Brief: Cytek Biosciences Q3 Revenue USD 48 Million Vs. IBES Estimate USD 55.5 Million
07/11/2023 21:05
Nov 07 (Reuters) - Cytek Biosciences Q3 net income USD -6.456 million. * Q3 adjusted EBITDA USD 3.72 million * Q3 pretax profit USD -4.185 million * outlook FY revenue USD 188-192 million
Recent news on Cytek Biosciences
See all newsCytek owes Beckman Coulter $56 mln in cell-analysis patent case, US jury says (updated)
Cytek owes Beckman Coulter $56 mln in cell-analysis patent case, US jury says
Cytek Biosciences, Inc. reports results for the quarter ended June 30 - Earnings Summary
Cytek Biosciences Q2 revenue slightly misses estimates
Brief: Cytek Biosciences Q2 Revenue USD 48.14 Million